IBT Bioservices RVSV-Pseudotyped Ebola Virus GP (RVSV-EBOV-GP)
SKU: 1001-001
IBT Bioservices RVSV-Pseudotyped Ebola Virus GP (RVSV-EBOV-GP)
Summary
- Recombinant Vesicular Stomatitis Virus (rVSV) pseudotyped with Ebola virus glycoprotein (rVSV-EBOV-GP) system in which the G protein of VSV has been deleted, replaced with firefly luciferase and used to produce VSV-pseudotyped virus containing the envelope glycoprotein of Ebola virus. Since the infectivity of pseudotyped virus is restricted to a single round of replication, analyses of viral entry can be performed using just biosafety level 2 (BSL-2) containment.
- Formulation & Storage: Supplied in EMEM™ (Gibco) supplemented with 1% Fetal Bovine Serum, Lglutamine and Penicillin/Streptomycin. Store at -80°C.
- Notes & Usage Guidelines:
- Recommended Dilution: 1:40
- Luciferase Units for Assays: 30,000
- Reporter: Luciferase
Overview
| PRODUCT NAME |
rVSV-pseudotyped Ebola virus GP (rVSV-EBOV-GP)
|
|
PRODUCT TARGET |
Recombinant Vesicular Stomatitis Virus pseudotyped Ebola glycoprotein |
|
PRODUCT ABBREVIATION |
rVSV pseudotyped EBOV GP |
|
PATHOGEN STRAIN |
Zaire |
|
TARGET PATHOGEN |
Ebola Virus |
|
PRODUCT CATEGORY |
Pseudovirus, Filoviruses |
|
PRODUCT TYPE |
Pseudovirus |
|
EXPRESSION |
HEK-293T cells |
|
APPLICATIONS |
Neutralization |
Properties
- Form: Liquid
- Formulation: Supplied in Advanced DMEM supplemented with 1% Fetal Bovine Serum, L-glutamine and Penicillin/Streptomycin
- Storage: -80°C
- Concentration: Batch dependent
MSE Supplies is an authorized distributor of IBT Bioservices products.